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Abstract
   We examined glucose and fructose effects on serine phosphorylation levels of a range
of proteins in rat liver and muscle cells. For this, healthy adult rats were subjected to
either  oral  glucose or fructose loads.  A mini-array system was utilized to  determine
serine phosphorylation levels of liver and skeletal muscle proteins. A glucose oral load
of 125mg/100g body weight (G 1/2) did not induce changes in phosphorylated serines
of the proteins studied. Loading with 250mg/100g body weight of fructose (Fr), which
induced similar glycemia levels as G 1/2, significantly increased serine phosphorylation
of liver cyclin D3, PI3 kinase/p85, ERK-2, PTP2 and clusterin. The G 1/2 increased
serine levels of the skeletal muscle proteins cyclin H, Cdk2, IRAK, total PKC, PTP1B,
c-Raf 1,  Ras and the  β-subunit  of the insulin receptor.  The Fr induced a significant
increase only in muscle serine phosphorylation of PI3 kinase/p85. The incubation of
isolated rat  hepatocytes  with 10mM glucose for 5 min significantly increased serine
phosphorylation of 31 proteins. In contrast, incubation with 10mM fructose produced
less intense effects. Incubation with 10mM glucose plus 75µM fructose counteracted
the effects of the incubation with glucose alone, except those on Raf-1 and Ras. Less
marked effects were detected in cultured muscle cells incubated with 10mM glucose or
10mM glucose plus 75µM fructose. Our results suggest that glucose and fructose act as
specific  functional  modulators  through  a  general  mechanism  that  involves
liver-generated  signals,  like micromolar  fructosemia,  which would inform peripheral
tissues of the presence of either glucose- or fructose-derived metabolites. 
Keywords: glucose, fructose, function modulators, liver, skeletal muscle.
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Introduction
   The rapid, relatively recent dietary changes in Western societies have highlighted the
effects  of  ingesting  certain  sugars.  Thus,  substitution  of  glucose  by  other  glucide
sweeteners, such as fructose, has revealed unexpected side-effects, like transient uric
acid peaks in serum (1), elevated cholesterol, lipid dysregulation (2), leptin resistance
(3), inflammatory responses in tissues like the kidney (4), and hypertriglyceridemia and
metabolic syndrome associated with insulin resistance (5-7). The differences between
glucose and fructose are attributed to the distinct ways in which they are metabolized in
the liver. Thus, while glucose is metabolized in hepatocytes via glucose 6-phosphate (G
6P), mainly through the hexokinase-I/glucokinase pathway, fructose is metabolized via
fructose 1-phosphate (F 1P), mainly through the fructokinase (FK) pathway (8,9). These
distinct pathways lead to specific changes in intracellular levels of crucial regulatory
metabolites, such as G 6P, glycogen and ATP, thus inducing sugar-specific changes in
the rhythm of metabolic pathways like gluconeogenesis, glycogenesis, lipid synthesis
and  urea  metabolism  (8,9).  These  changes,  in  turn,  lead  to  alterations  in  serum
concentrations of metabolic products, such as triglycerides and uric acid (1,2). 
   However,  the  difference  in  serum metabolite  levels  after  liver  metabolization  of
glucose  and  fructose  are  not  the  only  way  through  which  these  sugars  exert  their
specific  in vivo effects. In fact, alone, these sugars act directly on key points of the
regulatory function of several cells and tissues. Moreover, some of these actions do not
appear to be related to the modulation of the expression of certain genes but are linked
to specific changes in the general actions of proteins present in the cell, thus inducing
rapid  effects  that  trigger  further  physiological  alterations  in  target  tissues.  As  an
example,  glucose  potentiates  vascular  smooth  muscle  cell  chemotaxis  through  a
phosphatidylinositol  3-kinase  and  mitogen-activated  protein  kinase-dependent
up-regulation of the platelet-derived growth factor receptor (10). Another example is the
glucose-mediated  activation  of  the  protein  kinase  B  (Akt)  and  the  subsequent
up-regulation of TGF-β1 in mesangial cells through a pathway that is dependent on the
activity of the protein kinase C-β1 (11). Likewise, one of the key signals that induces
pancreatic insulin secretion is linked to the glucose-induced tyrosine phosphorylation of
protein p125 in beta cells and pancreatic islets (12). Fructose also has specific effects on
the activity of certain proteins. An example is the fructose-induced insulin resistance in
adipose tissue, which is linked to activation of the protein kinase C (13). Other well
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known  fructose-induced  alterations  in  insulin-sensitive  tissues  are  associated  with
changes  in  cell  signalling  and inflammatory  pathways  through modification  of   the
activity of proteins like tumor necrosis alpha (TNFα), c-Jun amino terminal kinase 1
(JNK 1),  protein  tyrosine  phosphatase  1B  (PTP-1B),  liver  X  receptor,  farnesoid  X
receptor and sterol regulatory element-binding protein-1c (SREBP-1c; see 6). However,
little is known about the mechanism/s underlying the origin of these effects and their in
vivo regulation by the liver.
   The  liver  is  the  main  regulatory  tissue  of  sugar  metabolism and the  subsequent
utilization of these molecules in the body. Here we aimed to establish a unified view of
the differential  effects  of  the  in  vivo administration  of  glucose  and fructose  on this
organ.  For  this  purpose,  healthy adult  rats  were  subjected  to  an oral  load  of  either
fructose or glucose at a range of doses. Using a mini-array system, we then analyzed the
phosphorylation  levels  of  proteins  linked  to  cell  cycle  control,
phospho-dephosphorylation regulatory mechanisms, and cell-to-cell interactions in liver
and in the most important peripheral tissue with respect to sugar consumption, such as
skeletal muscle. Furthermore, a similar analysis was performed in isolated hepatocytes
from starved healthy rats and from cultured rat skeletal muscle L6E9 cells incubated
with fructose or glucose, in order to gain further insight into the nature of the changes
induced by these sugars in these cell types. 
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Material and Methods
 Animals and in vivo treatment protocols
   All  animal  procedures  and treatment  protocols were in  accordance  with the Law
5/1995 on Animal Protection for Research and other Scientific Purposes (Generalitat de
Catalunya,  Spain).  From  this  Law,  the  University  of  Barcelona  developed  its  own
ethical protocols guidelines that follow all of the international ones. Under this basis,
the  animal  procedures  and  treatment  protocols  utilized  in  this  work  have  been
specifically approved by the Institutional Animal Care and Use Committee (IACUC) of
the University of Barcelona. Following this specific approval, healthy adult male Wistar
HsdOla:WI rats of 8 weeks of age as a mean weight of 200 g and without any genetic
modification or other previous manipulations were utilized. Animals were housed in a
SPF facility [Plataforma de Recerca Aplicada a l’Animal de Laboratori (PRAAL-PCB);
Barcelona  Science  Park,  University  of  Barcelona]  in  which  they  were  housed  in
polysulfone Type III shoebox cages (Tecniplast; Varese, Italy). Bedding material used
was autoclaved aspen wood. Rats were house 2 each per cage. Animals were kept under
a  constant  12h-12h  light-dark  cycle  at  20ºC-22ºC  and  at  a  relative  humidity  of
50%-60%. They were allowed to eat and drink ad libitum. All animals were health- and
welfare-assessed  daily.  Prior  to,  during  and  after  the  experiments  further  welfare
assessment was performed by researchers and technicians of the facility.  Animals were
fasted  24  h  before  the  start  of  the  in  vivo oral  sugar  load.  The  final  step  of  the
experimental study was in all cases carried out between 9:00 AM and 11:30 AM. This
final  step  was  performed  at  the  facilities  of  the  PRAAL-PCB.  Animals  were  then
divided into 6 groups.  The first  group (Control)  was immediately anesthetized  with
halotan in a specifically designed chamber to obtain a halotan saturated atmosphere and
subsequently  killed  by  decapitation.  Halotan  was  selected  because  being  a  potent
anaesthesic  that  completely  avoided  any  subsequent  pain  of  suffering  of  animals
inducing  minimal  effects  on  the  evaluated  parameters.   The  other  5  groups  were
intragastrically intubated and administered a 5 mL solution as follows:
 Saline group: 0.9% (w/v) NaCl solution (saline solution).
Glucose  1/4  group  (G  1/4):  65  mg/100  g  body weight  of  glucose  in  saline
solution.
Glucose  1/2  group  (G  ½):  125  mg/100  g  body  weight  of  glucose  in  saline
solution.
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Glucose group (G): 250 mg/100 g body weight of glucose in saline solution.
Fructose group (F): 250 mg/100 g body weight of fructose in saline solution.
In each case, animals from the same experimental group were caged together with a
total  of 2 animals per cage.  Intragastrical  intubation was immediately removed after
administration of the solutions and animals were returned to their  cages for 30 min.
They  were  then  anesthetized  with  halotan  and  killed  by  decapitation  as  previously
indicated. Immediately before the intragastric load, an aliquot of blood of approximately
10 μL was taken from each animal through tail puncture in order to measure glycemia.
Immediately after decapitation, blood was collected in heparinized tubes while liver and
longissimus dorsi muscle samples were dissected and frozen in liquid N2 for further
processing.  Each  experimental  group  was  composed  by  5  rats.  This  number  was
established following our previous experience with other experimental designs based in
the obtainment of information through a mini-array system in which the same number
of separate replicates was utilized as a minimally significant to yield relevant results
(14). Thus, the total number of animals utilized for the in vivo experimental procedure
was  of  30.  In  all  cases,  animals  were  processed  during  the  final  steps  of  the
experimental procedure following a random order of processing.
Preparation and incubation of hepatocytes 
   Hepatocyte suspensions were prepared from healthy adult male Wistar HsdOla:WI
rats of 8 weeks of age and weighted 200 g that were previously fasted for 24 h, as
described in (15). The total number of animals utilized for this purpose was of 5. In this
way, the total number of animals utilized in this work after summing those utilized in
the in vivo experimental procedure and those used for the isolation of hepatocytes was
of 35. Cells were resuspended in Krebs-Ringer bicarbonate buffer (pH 7.4). Samples (4
mL) of these suspensions, containing 4-5x106 cells/mL, were incubated at 37ºC with
gassing and continuous shaking (100 strokes/min). Glucose and fructose were dissolved
in a saline solution at a concentration of 1 M. Suitable volumes of these solutions were
added to the cell suspensions to obtain the desired final concentration (10mM in all
cases). Control hepatocytes were incubated with the same volume of saline solution.
After 5 min of incubation, cells were centrifuged (3000 g for 20 s) and pellets were
immediately frozen in liquid N2 until their subsequent processing.
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Preparation and incubation of cultured skeletal muscle cells 
   We utilized  rat  L6E9 myoblasts,  which were kindly donated by Dr.  Anna Gumà
(University  of  Barcelona).  Myoblasts  were  grown  in  DMEM  medium  (Invitrogen;
Carlsbad,  CA,  USA)  containing  25mM  glucose  and  supplemented  with  25mM
4-(2-hydroxyethyl)-1-piperazineethanesulfonic  acid  (HEPES)  and  10%  (w:v)  fetal
bovine serum (FBS).  Cells  were cultured until  reaching confluence.  They were then
induced to fuse by means of incubation in DMEM medium containing 25mM glucose,
25mM HEPES and 2% (w:v) FBS for 5 days. Afterwards, the differentiated myotubes
were then incubated for 18 h in DMEM medium with any addition before being used in
the  experiments.  As  in  case  of  hepatocytes,  the  incubation  of  the  differentiated
myotubes with the utilized monosaccharides was of 5 minuts. Afterwards, cells were
centrifuged (3000 g for 20 s) and pellets were immediately frozen in liquid N2 until their
subsequent  processing.  The  time  of  incubation  of  5  minuts  was  chosen  both  in
hepatocytes and myotubes as a good mean time in which any putative effect of sugars
on  phosphorylation  levels  can  be  easily  detected,  following  all  of  the  literature
accumulated at this respect in the last 50 years.
Mini-array analysis of selected proteins from tissue and cell extracts 
   Liver  and  muscle  tissues,  as  well  as  resuspended  hepatocytes  samples  were
homogenized in 1 mL of an ice-cold extraction solution comprising a 15mM Tris/HCl
buffer (pH 7.5) plus 120mM NaCl,  25mM KCl,  2mM EGTA, 2mM EDTA, 0.1mM
DTT,  0.5%  Triton  X-100,  10  µg/mL leupeptin,  0.5mM  PMSF  and  1mM  Na2VO4
(extraction solution) using a Polytron. Homogenized samples were then left for 30 min
at 4ºC and then centrifuged at 10,000 g for 15 min at 4°C. Supernatants were taken and
then used to test the degree of tyrosine, serine and threonine phosphorylation of selected
proteins included in a Custom AntibodyArrayTM (Hypromatrix, Inc. Worcester, MA,
USA),  following the standard protocol  provided by the manufacturer.  Briefly,  each
sample was diluted in 2 mL of extraction solution containing 1% dry milk to reach a
final protein concentration of 2 µg/ µL. Simultaneously, Antibody ArrayTM membranes
were  placed  in  suspension  culture  dishes  (60mm  x  15mm;  Corning  Incorporated;
Corning, NY, USA) and incubated with a blocking solution containing 150mM NaCl,
25mM Tris and 0.05% (v:v) Tween-20 (TBST; pH 7.5) plus 5% (w:v) dry milk and left
for 1 h at room temperature under slow shaking. Membranes were then incubated with
the  samples  for  2  h  at  room  temperature  under  slow  shaking.  After  incubation,
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membranes were washed 3 x 15 min with TBST. They were then incubated with 10
µg/mL HRP-conjugated anti-phosphoserine antibody (HM2070; Hypromatrix).  At the
same time, preliminary experiments involving the determination of phosphotyrosine and
phosphoserine phosphorylation levels of the proteins were performed. For this purpose,
HRP-conjugated  anti-phosphotyrosine  (HM2040;  Hypromatrix)  and
anti-phosphothreonine (HM2090; Hypromatrix) were also utilized. However, since the
results  obtained  with  the  phosphotyrosine  and  phosphothreonine  antibodies  were
unconsistent,  they  were  not  included  in  this  work  (data  not  shown).  In  all  cases,
antibodies were diluted in TBST and array membranes  were subsequently incubated
with these antibodies for 2 h at room temperature under slow shaking. Finally, samples
were washed 3 x  15 min  with  TBST and then  incubated  with  peroxidase  substrate
(ECL-Plus  Western  Blotting  Detection;  GE  Healthcare  UK  Ltd,  Buckinghamshire,
England) and exposed to X-ray film (Amersham Hyperfilm ECL; GE Healthcare UK
Ltd,  Buckinghamshire,  England).  The  total  protein  content  of  the  supernatants  was
determined by the Bradford method (16) using a commercial kit (Bio-Rad Protein Assay
Dye Reagent; Bio-Rad Laboratories). The intensity of the spots obtained was quantified
using  specific  software  for  image  analysis  of  blots  and  arrays  (Multi  Gauge  v3.0;
Fujifilm  Europe;  Düsseldorf,  Germany),  in  which  the  background  was  previously
standardized for all the arrays analyzed. The values obtained for the control samples, i.e.
those incubated in the absence of sugars, were transformed in order to obtain a basal
arbitrary value  of  100,  from which  the  intensity  values  for  the  other  samples  were
calculated. Furthermore, two types of negative control were applied. In one, two arrays
were incubated with a randomly chosen sample but without further incubation with the
primary  antibody.  In  the  other,  two  arrays  were  incubated  with  the  antibodies  but
without samples. The proteins included in this study are described in Fig. 1. All the
antibodies  included  in  the  arrays  were previously tested  for  their  specificity  for  rat
tissues by the manufacturer of the array.
   
Analytical procedures in serum samples 
   Glycemia  was  measured  by  the  hexokinase  method  and  fructosemia  by  the
fructokinase  technique.  Both  determinations  were  performed  using  the  appropriate
commercial  kits  (Roche Biomedical;  Basel,  Switzerland).  Serum insulin  levels  were
determined by an enzyme-linked immunosorbent assay (ELISA) using a commercial kit
(Crystal Chem, Chicago, ILL).
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Determination of ATP and G 6P in resupended hepatocytes 
   Frozen  cellular  pellets  were  homogenized  in  1  mL 10%  (v/v)  ice-cold  HClO4.
Homogenates  were  centrifuged  at  10,000  g for  15  min  at  4ºC  and  the  resultant
supernatants  were neutralized  with 5M K2CO3 before analysis.  G 6P and ATP were
determined enzymatically as in (17) and (18), respectively.
   
Statistical analysis 
   Statistical analyses were performed using SPSS 15.0 for Windows
 (SPSS Inc., Chicago, IL, USA) and data are presented as means±S.E.M. Data were
tested for normality and homoscedasticity using the Shapiro–Wilk and Levene tests.
When necessary, data were transformed using arcsine square root before a generalised
estimating  equation  (GEE),  an  extension  of  generalised  linear  model  (GLM)  for
repeated-measures, was performed. Characteristics of the GEE were normal distribution
and identity  link function.  The inter-subject  factor  was treatment.  In all  cases,  each
sugar  administration/incubation  was  the  dependent  variable  and  multiple  post  hoc
comparisons were calculated using Sidak’s test. In all statistical analyses, the minimal
level of significance was set at P<0.05. However, since the analytical technique has an
intrinsic  subjective  component,  we considered  true  differences  to  be  only  those  for
which P<0.05 and with a percent difference above 20%.
Suppliers
   All chemical reagents were of analytical grade and were obtained from Sigma (Saint
Louis, MO), Merck (Darmstadt, Germany), Bio-Rad Laboratories (Hercules, CA) and
EMS (Fort Washington, PA).
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Results
Changes  in serum  levels  of  glucose,  fructose  and  insulin  and in  serine
phosphorylation  levels  of  proteins  linked  to  cell  cycle  regulation  and
phosphor/dephosphor-ylation mechanisms in rats subjected to an oral glucose or
fructose load
   Oral administration of 250 mg of glucose/100 g body weight (G) induced an increase
in  glycemia  from 5.9mM±0.3mM  to  13.0mM±1.1mM  after  30  min  (Table  1).  The
administration  of  the  same dose  of  fructose  produced  a  lower  increase  (P<0.05)  in
glycemia, which reached values of 9.8mM±0.9mM after 30 min. Interestingly, the oral
administration of 125 mg of glucose/100 g body weight (G 1/2) increased glycemia
after  30 min  to  values  similar  to  that  reached with 280 mg of  fructose/100 g body
weight  (9.5mM±0.9mM  after  glucose  administration,  see  Table  1).  Oral  saline
administration  did not  modify glycemia,  thereby indicating  that  the values  observed
were not influenced by the administration technique used.
   The oral administration of glucose did not induce measurable values of fructosemia at
any of the loads tested. In contrast, the oral fructose loads caused fructosemia, which
reached 73.8µM±6.0µM after  30 min  (Table 1).  Concomitantly,  insulinemia  reached
maximal  values  30  min  after  the  glucose  load  (from  62.3mIU±L9.9mIU/L before
administration to 251.6mIU/L±12.3mIU/L after loading of 250 mg/100 g body weight
glucose, see Table 1). Fructose administration induced a lower increase in insulinemia
than that  caused  by the  maximal  glucose  load.  However,  insulinemia  after  fructose
loading  was  not  significantly  different  to  that  detected  in  animals  after  the
administration  of  G  1/2  (193.0mIU/L±11.2mIU/L  in  rats  receiving  fructose  vs.
217.4mIU/L±10.8mIU/L in those receiving G 1/2, Table 1).
   The oral administration of saline did not induce any significant change in the serine
phosphorylation levels of the proteins compared to rats that received non-intragastric
infusion. The minimal load of 65 mg/100 g body weight did not cause any significant
change in the serine phosphorylation levels of any of the proteins studied (Fig. 2 and
Table 2). In contrast, the maximal glucose load of 250 mg/100 g body weight caused a
significant (P<0.05) increase in this parameter for liver total protein kinase C, ERK-2,
protein phosphatase PTP1B, c-kit and clathrin, when compared with saline-treated rats
(Fig. 2 and Table 2). Remarkably, the highest glucose load also induced a very intense
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and  significant  (P<0.05)  increase  in  the  serine  phosphorylation  levels  of  cyclin  D3
(from 100.0±5.1 arbitrary units in saline-loaded animals to 180.9±6.4 arbitrary units in
high glucose-loaded animals, see Fig. 2 and Table 2). The fructose load also induced an
increase (P<0.05) in serine phosphorylation of several liver proteins, like ERK-2, PTP2,
cyclin D3, PI3 kinase/p85 and clusterin  (Fig.  2 and Table 2). However, of note,  the
highest glucose load increased serine phosphorylation of total PKC, PTP1B, c-kit and
clathrin, while the highest fructose load increased that of PI3 kinase/p85, clusterin and
especially PTP2 (Fig. 2 and Table 2). Remarkably,  comparison of the oral treatments
that rendered similar glycemia and insulinemia levels, namely the oral load of 125 mg
of glucose/100 g body weight (G 1/2) and the oral  fructose load,  revealed a totally
different behavior of the two experimental groups. Thus, the G ½ load did not induce
any significant increase in the serine phosphorylation of any of the proteins analyzed.
This finding clearly contrasted with that found for the fructose load, which, as indicated
above, caused several significant (P<0.05) increases (i.e., PTP2 went from 100.0±4.0
arbitrary units after saline load to 107.7±5.3 arbitrary units after G1/2 glucose load and
to 142.4±6.2 arbitrary units after fructose load, see Fig. 2 and Table 2).
   The effects of oral monosaccharide administration on serine phosphorylation levels of
skeletal  muscle  proteins  differed  to  those  observed  in  liver.  Again,  the  oral
administration of either saline or 65 mg glucose/100 g body weight did not significantly
modify  any  protein.  Furthermore,  the  maximal  glucose  load  induced  an  increase
(P<0.05) in serine phosphorylation of muscle total PKC, PI3 kinase/p85, IRAK, PTP1B,
cyclin H, Cdk2, c-Raf 1, ras, clusterin and the β subunit of the insulin receptor (Fig. 2
and Table 3). The administration of G1/2 glucose produced less intense effects, with a
significant (P<0.05) increase (P<0.05)  in muscle serine phosphorylation of cyclin H,
Cdk2, IRAK, PTP1B, total PKC, c-Raf, ras and the β subunit of the insulin receptor. In
contrast,  the  fructose  load,  which  induced  an  increase  in  glycemia  and insulinemia
similar to those observed after the administration of the G1/2 load, caused a significant
(P<0.05) increase only in the serine phosphorylation of muscle PI3 kinase/p85 (from
100.0±6.3 arbitrary units after saline administration to 136.6±6.4 arbitrary units after
fructose treatment; see Fig. 2 and Table 3). 
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Changes in intracellular G 6P and ATP levels and in serine phosphorylation levels
of  proteins  linked  to  cell  cycle  regulation  and  phospho/dephosphorylation
mechanisms  in  isolated  hepatocytes  incubated  in  the  presence  of  glucose  or
fructose 
   Isolated hepatocytes were incubated in media without sugars or in the presence of
three  distinct  combinations  of  monosaccharides.  The  rationale  behind  these
combinations  is  that  in  the  previously  described  in  vivo experimental  design,
hepatocytes  were subjected  to  different  concentrations  of  sugars  depending on their
specific location in the liver. Thus, after a glucose load all hepatocytes were exposed to
a similar glucose concentration, which was the one determined by blood glucose levels.
On  the  contrary,  after  the  fructose  load,  liver  hepatocytes  were  classified  into  two
conditions.  Those  in  contact  with  portal  blood  were  incubated  with  about  10mM
fructose,  while  those  in  contact  with  peripheral  blood  were  maintained  under  high
concentrations of glucose (about 10mM) and very low concentrations of fructose (about
75µM). Thus, our next experimental design was based on the incubation of isolated
hepatocytes from starved healthy rats in the presence of 10mM glucose, 10mM fructose
or  10mM  glucose  plus  75µM  fructose  in  order  to  mimic  the  range  of  conditions
observed in hepatocytes in vivo. 
   The incubation of hepatocytes with 10mM glucose for 5 min induced a significant
(P<0.05) increase in the intracellular levels of both G 6P (27.9 nmol/mg protein±4.7
nmol/mg protein vs. 16.2 nmol/mg protein±3.4 nmol/mg in control cells) and ATP (2.24
µmol/mg protein±0.63 µmol/mg protein vs.  1.09 µmol/mg protein±0.61 µmol/mg in
control cells; see Table 4). The 5-min incubation in the presence of 10mM fructose also
led to an increase in G 6P levels that was similar to that induced by 10mM glucose.
Notwithstanding,  fructose  caused  a  concomitant,  significant  (P<0.05)  decrease  in
intracellular ATP levels, which reached values of 0.51 µmol/mg protein±0.09 µmol/mg
(Table 4). The incubation of isolated hepatocytes with 10mM glucose+75µM fructose
for 5 min caused a strong increase in G 6P levels, with values about 100% higher than
those observed after the incubation with either glucose or fructose alone (Table 4). The
combination  of glucose and fructose also induced a  significant  (P<0.05)  increase  in
intracellular ATP levels, although in this case the increase was similar to that induced by
the incubation with glucose alone (Table 4).
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   Incubation of cells with 10mM glucose induced a strong and significant (P<0.05)
increase  in  the  serine  phosphorylation  levels  of  practically  all  the  proteins  tested,
reaching more than 2-fold increases in protein kinases such as IRAK, PYK2 and PI3
kinase/p85, cell cycle regulating proteins such as cyclins A, B and E and Cdk2, and
other proteins, such as c-kit and clathrin (Fig. 3 and Table 4). Remarkably, the effect of
the incubation with 10mM fructose was much less intense. In this regard, there were
only three proteins, namely Cdk2, Cdk4 and Hsp-70, in which the increase in serine
phosphorylation was similar after incubation with either glucose alone or fructose alone
(Fig. 3 and Table 4). In proteins such as cyclins A, B, E and H, Cdk1-cdc2, Cdk6, cdc6,
total Akt, IRAK, PYK2, PI3 kinase/p85, ERK-1, ERK-2, total tyrosine kinase, PTP2,
c-kit  and  clathrin,  the  fructose-induced  increase  in  serine  phosphorylation  was
significantly lower (P<0.05) than that induced by glucose. Furthermore, in contrast to
glucose,  incubation  with  fructose  did  not  significantly  change  the  serine
phosphorylation  levels  of  cyclin  D3,  cdc  25A,  total  protein  kinase  C,  total  protein
phosphatases (PP1, PP2A, PP2B and PPX), GSK-3, PTP1, PTP1B, caspase 9, Raf-1,
ras, clusterin or the β subunit of the insulin receptor (Fig. 3 and Table 4). Remarkably,
the incubation  of hepatocytes  with 10mM glucose plus 75µM fructose counteracted
practically  all  the  glucose-  and  fructose-induced  increases  observed  in  serine
phosphorylation  levels  (Fig.  3  and  Table  4).  Finally,  the  joined  glucose/fructose
incubation induced a significant (P<0.05) decrease in serine phosphorylation levels of
proteins like cyclin D3 and Hsp-70 (Fig. 3 and Table 4) 
Changes in intracellular G 6P and ATP levels and in the serine phosphorylation
levels of proteins linked to cell  cycle regulation and phospho/dephosphorylation
mechanisms in cultured skeletal muscle cells incubated in the presence of glucose
or fructose
   As in the case of hepatocytes, the in vivo experimental design led to the presence of
two distinct blood sugar environments for skeletal muscle cells. Thus, after the glucose
load, these cells were exposed to a high blood glucose concentration of about 10mM.
After the fructose load, muscle cells were exposed to glucose concentrations around 10
mM, which was accompanied with a concomitant exposure to very low concentrations
of fructose (about 75µM). Given these observations, our next experimental design was
based on the incubation of cultured skeletal muscle cells from starved healthy rats in the
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presence of 10mM glucose or 10mM glucose plus 75µM fructose in order to mimic the
range of conditions observed in skeletal muscle cells in vivo.
   The incubation of these cells in the presence of 10mM glucose for 5 min induced a
strong and  significant  (P<0.05)  increase  in  the  intracellular  concentrations  of  G 6P
(from 6.8±1.4 nmol/mg protein in basal cells to 16.8±2.4 nmol/mg protein after glucose
incubation) and ATP intracellular levels (from 0.80±0.06 µmol/mg protein in basal cells
to 5.12±1.87 µmol/mg protein after glucose incubation, see Table 5). Incubation in the
same conditions but with the addition of 75 µM fructose rendered increases in G 6P and
ATP intracellular levels that were not significantly different to those observed in the
presence of glucose alone (Table 5).
   Strikingly,  the  presence  of  75µM  fructose  altered  the  effects  on  the  serine
phosphorylation levels shown by glucose alone. Thus, incubation with 10mM glucose
for 5 min induced a significant (P<0.05) in serine phosphorylation levels of a wide array
of proteins. The greatest increases were those observed in total Akt (from 100.0±5.3 to
198.4 ±6.6 arbitrary units), Ras, (from 100.0±5.9 to 194.4±6.0 arbitrary units), c-Raf-1
(from  100.0±6.0  to  180.8±6.4  arbitrary  units),  PYK2/CAKβ (from  100.0±5.7  to
178.8±7.1  arbitrary  units)  and  total  tyrosine  kinase  (from 100.0±5.8  to  173.4  ±6.9
arbitrary units, see Fig. 3 and Table 5). However, the serine phosphorylation levels of
Cdk6, cyclin E, IRAK, PI3 kinase/p85, ERK-1 and ERK-2, total protein kinase C, PTP
1 and PTP2 also significantly (P<0.05) increased. The incubation with 10mM glucose
plus 75µM fructose practically  prevented  all  the increases in serine phosphorylation
levels  induced  by  glucose  alone.  Thus,  the  glucose-induced  increases  in  the  above
mentioned proteins were blocked by the presence of 75µM fructose. In addition,  the
glucose-induced increases in total Akt (from 198.4±6.6 arbitrary units in the presence of
10mM glucose to 130.7±5.7 arbitrary units in the presence of 10mM glucose plus 75µM
fructose), cyclin  E (from 169.2±6.6 arbitrary units in the presence of 10mM glucose to
124.4±5.5 arbitrary units  in the  presence  of 10mM glucose plus 75M fructose)  and
c-Raf-1 were partially counteracted (from 180.8±6.4 arbitrary units in the presence of
10 mM glucose to 126.7 ±5.5 arbitrary units in the presence of 10mM glucose plus
75µM fructose, see Fig. 3 and Table 5). Finally, the presence of 75µM fructose induced
a decrease (P<0.05) in the serine phosphorylation levels of two proteins that were not
affected by the incubation with glucose alone, namely c-kit (from 100.0±4.5 arbitrary
units in control cells to 71.0 ±5.3 arbitrary units in the presence of 10mM glucose plus
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75µM fructose) and cyclin H (from 100.3±5.8 arbitrary units in control cells to 78.3±5.1
arbitrary units in the presence of 10mM glucose plus 75µM fructose, see Fig. 3 and
Table 5).
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Discussion
   Our results indicate that glucose and fructose oral loads induce sugar-specific and
rapid functional responses not only in liver but also in peripheral tissues like skeletal
muscle. The differential effects of these two sugars  in vivo are easily observed when
comparing the results obtained after loads that induced similar increases of glycemia to
about  9.5mM/10mM  and  insulinemia  to  about  200mIU/L  in  both  cases.  In  these
conditions,  with  similar  glycemia  and  insulinemia,  fructose  loading  induced  a
significant increase in serine phosphorylation levels of only muscle PI3 kinase/p85. On
the contrary,  oral  glucose loading increased  serine phosphorylation  levels  of muscle
cyclin H, Cdk2, IRAK, total PKC, PTP1B, c-Raf 1, Ras and the  β unit of the insulin
receptor,  without  affecting  muscle  PI3  kinase/p85.   This  observation  indicates  that
glycemia and/or insulinemia are not the sole factors involved in the differential effects
of  glucose and fructose on muscle,  since these  specific  effects  were  caused despite
similar values of blood glucose and insulin levels. In fact, that glucose is not the sole
factor involved in these specific effects is also highlighted in both isolated hepatocytes
and cultured muscle cells. While the addition of 10mM glucose to the former increased
serine phosphorylation levels of practically all of the proteins tested, in the latter the
effect was much less intense, and only 15 of the proteins showed an increase. Thus, we
propose that  other  factors  are  involved in  the observed effects  of sugars on protein
serine phosphorylation.
   Regarding the effects  observed  in  vivo in  liver  and isolated  hepatocytes,  several
questions arising from our results. The first concerns the comparison of effects between
the two experimental systems. Thus, it is evident that the response to sugars in vivo is
less intense than in isolated cells. This effect can be caused by several factors, being one
of  this  the  unavoidable  effect  of  anaesthesia  on  both  liver  and  muscle  metabolism.
However, since the effect of the anaesthesia will be of the same magnitude in all of the
experimental conditions studied, we can infer that these compounds will not affect the
specific  response of  the  utilized  sugars,  albeit  the intensity  of  the  effects  would be
changed in a similar intensity in all cases, regardless of the sugar utilized. Additionally,
we might highlight that in the case of fructose there are proteins in which the effect is
the contrary when comparing the results obtained in vivo and in isolated/cultured cells.
These distinct effects on whole liver and isolated hepatocytes can be attributed to the
experimental systems. In this regard, the treatment by which isolated hepatocytes are
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obtained modifies their membrane structure, and key membrane proteins like the insulin
receptor are altered during this process (19). This implies that the response to external
stimuli, such as sugars, differs between isolated hepatocytes and whole liver. Moreover,
the whole liver  has a  complex structure,  in  which two types  of  hepatocytes  can be
distinguished. The first  type,  centro-lobulillar  hepatocytes,  are in direct  contact with
portal blood and thus are direct targets for all the substances that arise from the portal
vein (20). The other cellular type includes hepatocytes that are in direct contact with the
peripheral  circulation  from hepatic  arteria  and veins  (20).  In  these cells,  the  effects
induced by portal  substances  are  mediated  through the centro-lobulillar  hepatocytes.
Thus, a hierarchy of effects induced by either portal fructose or portal glucose is exerted
in vivo. In contrast, hepatic suspensions mix both types of hepatocyte, thus eliminating
any possible hierarchical action of sugars. Thus, the hepatic suspension model will yield
results that differ to those observed  in vivo.  This is an unavoidable effect,  since the
separation of the two hepatocyte subpopulations is not possible in in vivo experiments.
There are other technical questions that difficult the overall interpretation of the results
shown here. Thus, the mini-array analysis can be only interpreted as a broad approach to
the specific  effects  determined in all  of the analyzed proteins.  This  implies  that  the
interpretation of the results obtained with the mini-array technique must be done with
caution and a more definitive interpretation of the results would be carried out with the
support of complementary techniques like Western blot. However, despite all of these
difficulties,  the  results  obtained  here  are  a  good  indication  that  both  glucose  and
fructose  has  specific  and  separate  effects  on  the  overall  hepatocyte  and  myocyte
physiology taken as a whole, although the precise ways by which these specificities are
launched can not be elucidate at this point.
   Despite all these differences and difficulties, the combined analysis of results obtained
in in vivo and in isolated and cultured cells allows us to draw a number of conclusions.
First, the effects of sugars are rapid, since they induce strong changes after only 5 min
of  incubation  in  both  isolated  and  cultured  cells.  Moreover,  the  different  effect  of
glucose and fructose appears to be associated with the sugar-specific changes observed
in the intracellular levels of metabolites like G 6P and ATP. Thus with regard to the
liver, the glucose-induced increase in ATP would activate phosphorylation pathways by
increasing substrate (9). Meanwhile, the fructose-induced decrease in ATP would induce
the opposite effect (21). It is noteworthy that the fructose-induced decrease in ATP in
hepatocytes is mainly a consequence of the low Km (about 0.5mM) of FK for fructose,
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which induces a very high velocity of fructose phosphorylation to fructose 1-phosphate
(22). In fact, the ATP lowering triggered by the fructose-FK system is at the basis of the
other  well  known  metabolic  alterations  induced  by  this  sugar,  such  as
hypertriglyceridemia  or the transient increase in serum uric acid (1,6,7). In fact,  the
mere presence of FK in liver is surprising at a first glance as hepatic cells can uptake
and metabolize fructose via other hexokinases, such as the ubiquitous hexokinase-I (23).
Thus FK appears to contribute to modulating the functional status of hepatocytes, which
would  change  their  overall  functional  activity  depending  on  the  specific  changes
induced by the FK pathway on the phosphorylation status of a wide range of proteins.
This hypothesis would also explain the presence of FK in the liver of animals whose
diets contain low fructose levels, like the dog and cat (24). In these animals, fructose,
via hepatic FK, would serve as a true modulator of hepatic function rather than merely a
direct energy source.
   However, while the effects of glucose and fructose on liver could be explained by a
direct, specific action of these two sugars through their portal door of entry, the effects
observed on peripheral skeletal muscle can not be attributed to the same direct effect. In
this regard, our results indicate that while glucose alone has a distinct effect on serine
phosphorylation  of  many  proteins,  fructose  alone  does  not.  In  fact,  hepatic
metabolization of fructose implies that, in the best of cases, fructosemia is consistently
in the µM range, whereas glycemia is in all cases in the mM range. The sugar-specific
effects observed in muscle would be due to an inducer that would be produced from
liver after the action of either portal glucose or portal fructose on this organ. We can
only speculate  regarding this  question,  although there  are  several  points  of  interest.
First, as indicated above, the sugar-specific actions do not appear to be related to the
specific  serum  glycemia  and/or  insulinemia,  since  these  effects  were  observed  in
conditions  in  which serum glucose and insulin  were  similar.  We propose that  other
factors  are  therefore  involved.  It  is  noteworthy  that  fructose-rich  diets  cause
hyperlipidemia  through  a  hepatic  mechanism  involving  FK  and  the  lowering  of
intracellular  hepatic  ATP  levels  (21).  Thus  the  increase  in  lipidemia  could  be  a
signalling  factor  of  fructose  ingestion  for  peripheral  tissues.  Notwithstanding,
fructosemia  itself  is  another  factor  related  to  the  fructose-linked  effects  in  skeletal
muscle. A specific effect of micromolar concentrations of fructose can be inferred after
analyzing the results observed in isolated skeletal muscle cells, in which the addition of
75µM of this sugar dramatically changed the glucose-induced effects on protein serine
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phosphorylation.  It  is  also  remarkable  that  these  fructose-linked  effects  were  not
associated with changes in intracellular G 6P or ATP contents, since the values of these
two metabolites were very similar in skeletal muscle cells incubated with glucose alone
or  with glucose  plus  fructose.  Regarding this  point,  there  are  a  series  of  paradoxes
related to in vivo fructose utilization. The genetic lack of liver FK induces fructosuria, a
benign  process  in  which  fructosemia  reaches  serum  concentration  values  of  mM;
however,  none of  the known side-effects  related  to  fructose metabolization,  such as
hypertension, hyperlypidemia and insulin resistance occur (25). In fact, one of the very
few complications that arise in fructosuria is the appearance of proximal renal tubular
acidosis,  which  is  caused  by  an  excess  of  kidney  filtration  of  fructose  (25).  This
observation contrasts with the presence of the specific fructose transporter GLUT5 in
skeletal muscle (26). The presence of this transporter indicates that these cells have the
capacity to take up fructose from the environment.  However, there are no signs that
peripheral muscle uses this sugar in conditions of fructosuria. Perhaps this paradox can
be explained by the concentration  of fructose reached in each condition.  In  healthy
individuals that present hepatic FK, the maximal fructosemia is in the µM range, not
mM as in fructosuria. Moreover, this fructosemia is always accompanied by glycemia
concentrations in the mM range. This finding is relevant as several studies carried out in
isolated hepatocytes indicate that the incubation of rat hepatocytes with 8mM glucose
plus 100µM fructose caused a dramatic increase in the glycolytic flux by raising the
intracellular levels of fructose 2,6-bisphosphate (Fru(2,6)P2) when compared with the
incubation  with  8mM  glucose  alone  (27).  The  effect  of  the  glucose-fructose
combination  was  accompanied  by  an  increase  in  intracellular  G  6P  through  a
mechanism linked to the glucose-and-fructose induced activation of liver glucokinase
(28). Remarkably,  the incubation of isolated hepatocytes with 100 µM fructose alone
did not increase the intracellular levels of either Fru(2,6)P2 or  G 6P (27). Thus the
induced increase in G 6P levels in hepatocytes incubated with glucose plus fructose
cannot be attributed to an increase in the pool of fructose 6-phosphate resulting from
fructose metabolism. These reflections raise the question as to the nature of the role
played by FK in the modulation of in vivo fructose signalling. At present, we can only
speculate on this question, and more experiments are required to elucidate the presence
of  a  putative,  co-operative  action  of  high  glucose  concentrations  and  low  fructose
concentrations on overall cell function.
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   The data collected using our experimental approach allows us to propose a general
hypothesis  to  explain  the  in  vivo functional  effects  of  glucose  and fructose.  In  this
hypothesis (see Fig. 4), the response of peri-portal hepatocytes to glucose and fructose
depends on changes in intracellular G 6P and ATP levels induced by the sugars. This
specific response is caused by the presence of separate phosphorylation mechanisms for
glucose (hexokinase-I/glucokinase system) and for fructose (FK system). The response
of peri-portal  hepatocytes  is  communicated  to  other  hepatic  cells  and the liver  as a
whole  signals  peripheral  tissues  to  indicate  the  sugar  source  of  the  circulating
metabolites.  These  signals  may  be  related  to  the  presence  of  metabolites  such  as
triglycerides  and  specifically  fructose.  Thus  peripheral  tissues,  like  skeletal  muscle,
would  respond  in  a  specific  manner  to  these  signals  by  changing  the
phospho-dephosphorylation levels of several key proteins, thereby inducing alterations
in the physiology of these cells. The response of each tissue to the specific signals from
the  liver  would  depend  on  the  processing  mechanisms  involved.  For  instance,  the
presence  of  GLUT  5  in  muscle  cells  would  be  explained  as  a  specific  response
mechanism for fructose-induced circulating function modulators.  In summary,  on the
basis  of  our  results,  we propose the  existence  of  a  general  in  vivo mechanism that
utilizes sugars as specific modulators of overall body sugar utilization.
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Figure 1.  General scheme of protein distribution for the mini-array analysis.
Figure  2.  Mini-array  analysis  of  the  serine  phosphorylation  status  of  several
proteins involved in overall cell function and the regulation of cell cycle in whole
rat liver and skeletal muscle after oral loading of different amounts of glucose and
fructose. The mini-array analysis and the distribution of the proteins are described in
the Material and Methods section and Figure 1. Healthy adult rats were subjected to an
oral glucose or fructose load, as described in the Material and Methods section. The
serine-phosphorylation  levels  of  each  spot  in  the  mini-arrays  were  then  analyzed.
Control: rats that were not subjected to an oral load. Saline: rats subjected to a mock
oral  load with xx mL of  saline  solution (0.9%; w/v,  NaCl in  fresh drinking water).
Glucose 1/4: animals subjected to an oral load of 65 mg glucose/100 g body weight.
Glucose 1/2: animals subjected to an oral load of 125 mg glucose/100 g body weight.
Glucose:  animals  subjected  to  an  oral  load  of  250 mg  glucose/100 g  body weight.
Fructose: animals subjected to an oral load of 280 mg fructose/100 g body weight. C-:
negative controls. Liver: whole liver extracts. Muscle: whole skeletal muscle extracts.
The  Figures  shows  a  representative  image  for  five  separate  experiments.  Negative
controls were designed as described in the Material and Methods section.
Figure  3.  Mini-array  analysis  of  the  serine  phosphorylation  status  of  several
proteins involved in overall cell function and the regulation of cell cycle in isolated
hepatocytes  and cultured skeletal  muscle cells  after incubation with a range of
concentrations of glucose, fructose or glucose plus fructose. The mini-array analysis
and the distribution of the proteins are described in the Material and Methods section
and Figure 1. Isolated hepatocytes and skeletal muscle cell cultures were obtained and
incubated as described in the Material and Methods section. The serine-phosphorylation
levels of each spot in the mini-arrays were then analyzed. Control: cells incubated for 5
min without the presence of any monosaccharide. Glucose: cells incubated for 5 min in
the  presence  of  10  mM  glucose.  Fructose:  hepatocytes  incubated  for  5  min  in  the
presence  of  10  mM  fructose.  Glucose+Fructose:  cells  incubated  for  5  min  in  the
presence of 10 mM glucose plus 75 µM fructose. Hepatocytes: isolated hepatocytes.
Muscle: skeletal muscle cell cultures. The figures shows a representative image for five
separate experiments. 
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Figure  4.  Diagram  explaining  the  postulated  hypothesis  given  to  explain  the
specific effects of fructose and glucose on the overall function of liver and skeletal
muscle  cells  after  ingestion  of/incubation  with  these  sugars. Following  this
hypothesis, peri-portal hepatocytes respond to glucose or fructose in a specific manner,
depending on the sugar-specific changes that intracellular G 6P and ATP levels undergo
in these cells  and,  perhaps,  other  unknown signalling mechanisms.  The response of
these  cells  is  communicated  to  other  hepatic  cells  and the  liver  as  a  whole  signals
peripheral tissues; this signalling, which is probably based on the presence or absence of
micromolar concentrations of fructose in circulating blood, in addition to other putative,
unknown signalling mechanisms, indicates that the circulating metabolites derive from
either glucose or fructose. Peripheral tissues, like skeletal muscle, would then respond
in a specific manner to these signals by changing the phospho-dephosphorylation levels
of several key proteins, thus inducing an alteration in the physiology of these cells.
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Table 1. Values of glycemia, fructosemia and insulinemia in rats subjected to either an oral glucose or
fructose load.
Control Saline Glucose 1/4 Glucose 1/2 Glucose Fructose 
Glycemia (mM) 5.9±0.3a 5.4±0.5a 7.0±0.4b 9.5±0.6c 13.0±1.1d 9.8±0.9c
Fructosemia (µM) 3.9±3.0a 3.9±3.5a 1.7±1.6a 1.1±1.1a 7.4±6.8a 73.8±7.0b
Insulinemia (mIU/L) 62.3±9.9a 84.1±9.6a 220.7±11.1b 217.4±10.8b 251.6±12.3c 193.0±11.2b
The experimental groups are described in the Materials and Methods section. Different superscripts in a
row indicate significant (P<0.05) differences following the statistical analysis described in the Material
and Methods section. Thus, data marked with an “a” in superscript are significantly different from those
marked with any other letter in the same file.  Results are expressed as means±S.E.M. for 5 individuals
in each experimental group.
Table 2. Relative increase in serine phosphorylation levels of selected liver proteins in rats subjected to
either an oral glucose or fructose load.
Control Saline Glucose 1/4 Glucose 1/2 Glucose Fructose 
Cyclin D3 96.1±4.9a 100.0±5.1a 96.6±4.7a 104.3±5.6a* 180.9±6.4b 147.2±6.7c*
PI3
kinase/p85
88.3±6.4a 100.0±7.1a 101.8±7.3a 117.3±7.6a 117.3±7.7a 123.9±7.7b
Total PKC 89.2±5.7a 100.0±6.2a 108.2±6.7a 121.0±7.0a 137.4±6.5b 121.0±5.3a
ERK-2 92.2±4.7a 100.0±5.1a 100.6±5.0a 121.7±5.8a 151.1±6.2b 127.8±6.0b
PTP1B 79.9±5.8a 100.0±5.9a 102.7±6.0a 104.5±5.7a 123.0±5.7b 107.2±5.7a
PTP2 (SH) 91.2±3.8a 100.0±4.0a 104.0±4.6a 107.7±5.3a* 120.1±5.9a 142.4±6.2b*
c-kit 98.0±3.3a 100.0±3.7a 103.0±3.2a 109.5±4.8a 131.1±4.7b 114.9±4.8a
Clathrin 78.6±4.2a 100.0±5.0a 100.6±4.9a 103.2±4.9a 134.1±5.6b 100.7±4.0a
Clusterin 93.5±4.0a 100.0±4.4a 86.9±4.7a 100.6±4.7a* 92.1±3.9a 130.4±4.9b*
Table shows proteins from arrays in which significant (P<0.05) differences above 25% were obtained
compared  to  control  or  saline.  Results  are  expressed  in  arbitrary  units,  transforming  the  intensity
obtained to 100 in control points. Different superscript letters in a row indicate significant  (P<0.05)
differences  among  values  from  the  same  row.  Thus,  data  marked  with  an  “a”  in  superscript  are
significantly different from those marked with any other letter in the same file. Additionally, superscript
asterisks indicate significant (P<0.05) differences between Glucose 1/2 values and Fructose ones. In both
cases,  differences  were  established  following  the  statistical  analysis  described  in  the  Material  and
Methods section. Acronyms for the proteins are described in Figure 1 while the experimental groups are
described in the Materials  and Methods section. Results are means±S.E.M. for 5 individuals in each
group.
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Table 3. Relative increase in serine phosphorylation levels of selected skeletal muscle
proteins in rats subjected to an oral glucose or fructose load.
Control
(n=5)
Saline (n=5) Glucose 1/4
(n=5)
Glucose 1/2
(n=5)
Glucose
(n=5)
Fructose
(n=5)
Cyclin H 110.7±4.9a 100.0±6.4a 109.3±5.1a 142.9±5.6b* 144.4±5.4b 109.4±6.1a*
Cdk2 106.8±6.6a 100.0±6.0a 105.9±6.5a 138.1±6.1b* 141.3±6.4b 99.8±5.7a*
IRAK 104.4±5.2a 100.0±5.5a 112.6±5.8a 127.4±5.6b* 138.4±5.3b 98.1±5.7a*
PI3 Kinase/p85 99.7±3.9a 100.0±6.3a 99.9±4.6a 117.6±6.9a* 123.7±6.5b 136.6±6.4b*
Total PKC 103.6±7.0a 100.0±5.7a 102.0±5.7a 128.3±5.3b* 140.6±6.0b 102.0±5.0a*
PTP1B 99.9±6.3a 100.0±4.6a 103.0±5.2a 131.7±5.4b* 138.2±6.1b 101.0±5.2a*
c-Raf 1 101.9±4.6a 100.0±4.2a 102.4±4.8a 141.8±5.3b* 151.0±5.7b 102.7±4.4a*
Ras 104.9±4.7a 100.0±5.2a 104.8±5.7a 132.0±6.9b* 150.5±5.1b 98.1±4.9a*
Clusterin 100.2±5.3a 100.0±5.5a 98.8±5.7a 109.2±5.8a 136.5±6.1b 123.1±6.6a
β subunit 
insulin receptor
106.0±5.2a 100.0±5.7a 104.3±5.6a 133.3±5.9b* 146.8±5.8b 108.6±5.2a*
Table shows proteins from arrays in which significant (P<0.05) differences above 25%
were  obtained.  Results  are  expressed  in  arbitrary  units,  transforming  the  intensity
obtained  to  100  in  control  points.  Different  superscript  letters  in  a  row  indicate
significant (P<0.05) differences among values from the same row. Thus, data marked
with an “a” in superscript are significantly different from those marked with any other
letter in the same file. Additionally,  superscript asterisks indicate significant (P<0.05)
differences between Glucose 1/2 values and Fructose ones. In both cases, differences
were established following the statistical analysis described in the Material and Methods
section.  Acronyms for the proteins are described in Figure 1 while the experimental
groups are described in the Materials and Methods section. Results are means±S.E.M.
for 5 individuals in each group.
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Table 4. Intracellular glucose 6-phosphate and ATP levels and relative increase in serine
phosphorylation levels of selected proteins of hepatocytes incubated in the presence or
absence of glucose or fructose.
Control 10 mM Glucose 10 mM Fructose 10 mM
Glucose+75 µ
Fructose
Glucose  6-phosphate  (nmol/mg
protein)
16.2±3.4a 27.9±4.7b* 21.1.±3.0ab 51.1±3.0c*
ATP (µmol/mg protein) 1.09±0.61a 2.24±0.63b 0.51±0.09c 2.82±0.89b
Cyclin A 100±4.9a 239.3±5.8b* 164.3±5.1c 82.3±4.9a*
Cyclin B 100±4.3a 222.4±5.6b* 173.1±4.8c 86.5±4.8a*
Cyclin D3 100±4.0a 190.7±5.0b* 119.3±4.1a 51.2±5.3c*
Cyclin E 100±5.1a 243.5±6.3b* 165.9±5.4c 146.2±6.2c*
Cyclin H 100±4.9a 192.3±6.2b* 146.2±5.5c 114.9±6.0a*
Cdk1-cdc2 100±6.1a 192.6±6.9b* 137.4±5.3c 131.9±5.8c*
Cdk2 100±5.5a 210.7±6.2b* 189.8±5.9b 108.8±5.1a*
Cdk4 100±5.3a 152.1±5.8b* 147.3±5.8b 114.6±4.9a*
Cdk 6 100±4.8a 192.7±5.4b* 136.4±4.9c 106.1±5.4a*
cdc 25ª 100±4.4a 147.5±4.9b* 107.5±4.3a 120.5±5.8a*
Cdc6 100±4.3a 186.74.8±b* 132.2±4.4c 119.7±5.6a*
AKT 1,2 100±5.3a 167.6±5.9b* 131.1±5.5c 105.2±4.9a*
IRAK 100±5.3a 241.0±6.1b* 172.2±5.0c 95.6±4.9a*
PYK2 100±5.8a 227.3±6.8b* 158.5±6.0c 100.7±5.0a*
PI3 kinase/p85 100±6.3a 222.1±6.9b* 159.1±5.7c 106.1±5.3a*
ERK1 100±6.0a 180.0±6.6b* 136.3±6.3c 112.0±5.6a*
Total PKC 100±4.9a 151.8±5.8b 106.4±5.3a 142.8±5.9b
ERK2 100±4.4a 188.0±5.9b* 125.3±5.5c 116.8±5.3a*
PP1,2A,2B,X 100±4.9a 188.6±5.1b* 115.0±4.4a 109.1±5.8a*
TRK A,B,C 100±5.0a 199.9±5.9b* 163.7±5.4c 113.3±5.3a*
GSK3 100±6.0a 149.0±6.6b* 114.8±5.8a 111.4±5.2a*
PTP1 100±5.2a 158.8±5.7b* 112.2±5.3a 99.5±5.7a*
PTP1B 100±5.3a 134.6±5.9b* 102.3±5.9a 165.4±6.3c*
PTP2 100±6.2a 161.3±5.7b* 144.7±6.1c 79.6±4.6d*
Caspase 9 100±5.7a 148.7±6.3b* 107.7±5.5a 102.5±4.9a*
c-kit 100±4.7a 209.0±5.8b* 147.8±4.6c 85.7±5.2a*
Raf-1 100±4.9a 174.7±5.9b 107.5±5.0a 161.0±5.7b
Ras 100±5.8a 162.1±6.2b* 118.7±5.8a 140.8±6.2c*
Clathrin 100±5.3a 217.2±6.0b* 172.2±5.8c 90.5±5.0a*
Clusterin 100±6.3a 150.8±6.4b* 118.1±6.6a 99.6±4.7a*
Hsp-70 100±5.8a 153.0±6.3b* 142.6±6.5b 78.3±4.0c*
β subunit insulin receptor 100±5.1a 131.0±5.8b* 106.2±5.0a 99.8±5.1a*
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Isolated hepatocytes were incubated for 5 min in the absence or the presence of 10 mM
glucose or 10 mM fructose, as described in the Material and Methods. The table shows
glucose 6-phosphate and ATP intracellular levels, as well as the relative degree of serine
phosphorylation of proteins in which differences above 25% were obtained. Results are
expressed in arbitrary units, transforming the intensity obtained to 100 in control points.
Different superscript letters in a row indicate significant (P<0.05) differences among
values from the same row. Thus, data marked with an “a” in superscript are significantly
different  from  those  marked  with  any  other  letter  in  the  same  file.  Additionally,
superscript asterisks indicate significant (P<0.05) differences between 10 mM Glucose
values  and  10  mM  Glucose+75µM  Fructose  ones.  In  both  cases,  differences  were
established  following  the  statistical  analysis  described  in  the  Material  and  Methods
section. Acronyms for the proteins are described in Figure 1. Results are means±S.E.M.
for 5 separate experiments.
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Table 5. Intracellular glucose 6-phosphate and ATP levels and relative increase in serine
phosphorylation levels of selected proteins from cultured skeletal muscle cells incubated
in the presence or absence of glucose or fructose.
Control 10mM Glucose 10mM
Glucose+75µM
Fructose
Glucose 6-phosphate 
(nmol/mg protein)
6.8±1.4a 16.8±2.4b 19.0±2.5b
ATP (µmol/mg protein) 0.80±0.06a 5.12±1.87b 5.41±1.96b
Akt 1/2 100±5.3a 198.4±6.6b 130.7±5.7c
Cdk6 100±5.4a 129.0±6.7b 87.0±5.0a
Cyclin E 100±6.4a 169.2±6.6b 124.4±5.5c
IRAK 100±4.6a 164.1±6.9b 111.6±5.7a
PYK2/CAKβ 100±5.7a 178.8±7.1b 96.9±6.0a
c-kit 100±4.5a 90.0±7.3a 71.0±5.3b
Cyclin H 100±5.8a 110.3±6.5a 78.3±5.1b
PI3 kinase/P85 100±5.8a 142.7±7.0b 96.3±5.0a
c-Raf-1 100±6.0a 180.8±6.4b 126.7±5.5c
ERK-1 100±6.4a 156.4±6.8b 92.8±5.9a
Total PKC 100±6.2a 156.5±7.1b 100.8±6.2a
Ras 100±5.9a 194.4±6.0b 106.6±5.0a
ERK-2 100±6.4a 139.5±6.3b 80.2±5.1a
Total Trk 100±5.8a 173.4±6.9b 98.9±6.1a
PTP1 (SH) 100±5.5a 142.1±6.4b 102.6±5.3a
PTP1 B 100±5.7a 163.9±7.1b 102.9±5.6a
PTP2 (SH) 100±6.3a 164.3±7.0b 103.7±5.5a
Isolated skeletal muscle cells were incubated for 5 min in the absence or the presence of
10 mM glucose or 10 mM fructose, as described in the Material and Methods. Table
shows glucose 6-phosphate and ATP intracellular levels, as well as the relative degree of
serine  phosphorylation  of  proteins  in  which  differences  above  25% were  obtained.
Results are expressed in arbitrary units, transforming the intensity obtained to 100 in
control points. Different superscripts in a row indicate significant differences following
the statistical analysis described in the Material and Methods section. Thus, data marked
with an “a” in superscript are significantly different from those marked with any other
letter in the same file. Acronyms for the proteins are described in Figure 1. Results are
means±S.E.M. for 5 separate experiments.
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